Developer docs
API playgroundTry for free, no card

Search company profiles

Crystalplex

Full company profile

uuid0005b4c

Namestring
Crystalplex
Websiteurl
crystalplex.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Crystalplex is a privately held for-profit company founded in 2004 and based in Pittsburgh, Pennsylvania. According to its firmographic description, the company provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company operates with a very small team of 1-10 employees, and its stated core capability is the formulation and supply of fluorescent nanoparticles used as reagents or labels in life-science research and clinical diagnostic workflows.

The company's capital history consists of seven small equity rounds between 2007 and 2018, totaling approximately $3.22M, with the only named institutional investor being Pittsburgh Life Sciences Greenhouse (2007 round). No product catalog, pricing model, patents, certifications, customer logos, distribution channels, or partnerships are documented in the available data. The technology block confirms no API, no integrations, no AI capabilities, and no disclosed product launches. Leadership comprises three named individuals: CEO Matt Bootman, founder Tom Petzinger, and CTO Lianhua Qu.

A material operational signal is that the company's primary web domain, crystalplex.com, is currently listed for sale on HugeDomains for $13,595, indicating the digital storefront is no longer active. No funding has been recorded since June 2018. The combination of a multi-year funding drought, absence of disclosed customers or products, and a parked-for-sale domain strongly suggests the company is in a dormant, declining, or wind-down state, although the available data does not definitively confirm a formal cessation of operations.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPittsburgh, United States
HQ citystring
Pittsburgh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
fluorescent nanoparticles, biomedical research reagents, molecular diagnostics, pathology imaging reagents, nanoparticle technology
Industry3 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
NAICS code2 codes
  • Research and Development in Nanotechnology541713
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Optical Instruments & Lenses3827
Product category
Biomedical Research Reagents
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company develops and supplies nanomaterial-based reagents and tools that enable detection, labeling, and imaging applications for life-science researchers and clinical diagnostic developers. Its offerings center on proprietary fluorescent nanoparticle formulations tailored to research and diagnostic use cases.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product or service information available. CrystalPlex.com is currently listed for sale as a domain name on HugeDomains.com for $13,595, with no active company website or product offerings detected in the source data.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

A dominant life-sciences tools and diagnostics incumbent that sells fluorescent reagents, particle-based assays, and imaging consumables, often competing with smaller nanoparticle specialists for the same biomedical research and pathology customers.

TypeDirect peer
Description

Develops and supplies gold and silver nanoparticles, including fluorescently labeled variants, to biomedical research, diagnostic, and life-sciences customers — closely aligned with Crystalplex's stated markets.

TypeDirect peer
Description

Specializes in fluorescent nanoparticles and quantum dots for biomedical research and diagnostic applications — the most direct functional overlap with Crystalplex's nanoparticle platform.

TypeDirect peer
Description

Manufactures functionalized and fluorescent nanoparticles, proteins, and bioconjugates sold into research and diagnostic applications, matching Crystalplex's product focus.

TypeEmerging player
Description

Designs and manufactures precisely engineered nanoparticles, including fluorescent versions, for diagnostics and life-sciences research customers.

TypeEmerging player
Description

Offers a growing catalog of fluorescent and magnetic nanoparticles for diagnostics and drug delivery — an emerging participant in the same niche as Crystalplex.

7MilliporeSigma (Merck KGaA Life Science)
TypeBroad incumbent
Description

Supplies an extensive catalog of fluorescent nanoparticles, dyes, and reagents for research and diagnostic workflows, representing a broad incumbent competitive reference point.

TypeDirect peer
Description

Supplies fluorescent and functionalized microparticles/nanoparticles for diagnostics, life-sciences research, and flow cytometry — directly comparable reagent offering.

TypeDirect peer
Description

Manufactures fluorescent and magnetic particles for diagnostic and research use, including flow cytometry applications, making it a directly comparable nanoparticle reagent vendor.

TypeBroad incumbent
Description

A molecular diagnostics and life-sciences research tools company whose bead-based and fluorescent assay platforms overlap with downstream uses of Crystalplex's fluorescent nanoparticle technology.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Crystalplex

Biomedical Research Reagentscrystalplex.com

What Crystalplex does

Crystalplex is a privately held for-profit company founded in 2004 and based in Pittsburgh, Pennsylvania. According to its firmographic description, the company provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company operates with a very small team of 1-10 employees, and its stated core capability is the formulation and supply of fluorescent nanoparticles used as reagents or labels in life-science research and clinical diagnostic workflows.

The company's capital history consists of seven small equity rounds between 2007 and 2018, totaling approximately $3.22M, with the only named institutional investor being Pittsburgh Life Sciences Greenhouse (2007 round). No product catalog, pricing model, patents, certifications, customer logos, distribution channels, or partnerships are documented in the available data. The technology block confirms no API, no integrations, no AI capabilities, and no disclosed product launches. Leadership comprises three named individuals: CEO Matt Bootman, founder Tom Petzinger, and CTO Lianhua Qu.

A material operational signal is that the company's primary web domain, crystalplex.com, is currently listed for sale on HugeDomains for $13,595, indicating the digital storefront is no longer active. No funding has been recorded since June 2018. The combination of a multi-year funding drought, absence of disclosed customers or products, and a parked-for-sale domain strongly suggests the company is in a dormant, declining, or wind-down state, although the available data does not definitively confirm a formal cessation of operations.

Crystalplex firmographics

Firmographics
Name
Crystalplex
Website
https://crystalplex.com
Company type
Private
Founded year
2004
Headcount range
1–10 employees
Ownership category
akta.pro rank

Crystalplex industry classification

Industry
Product category
Biomedical Research Reagents
NAICS
Research and Development in Nanotechnology (541713), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)

Keywords

  • Fluorescent nanoparticles
  • Biomedical research reagents
  • Molecular diagnostics
  • Pathology imaging reagents
  • Nanoparticle technology

Where Crystalplex is headquartered

Location

Headquarters

HQ city
Pittsburgh
HQ country
United States
HQ region
North America

Markets served

Crystalplex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Crystalplex product offering

Product offering

Core offering

Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company develops and supplies nanomaterial-based reagents and tools that enable detection, labeling, and imaging applications for life-science researchers and clinical diagnostic developers. Its offerings center on proprietary fluorescent nanoparticle formulations tailored to research and diagnostic use cases.

Product overview

No product or service information available. CrystalPlex.com is currently listed for sale as a domain name on HugeDomains.com for $13,595, with no active company website or product offerings detected in the source data.

Differentiator

Problem solved

Functional benefit

Companies that use Crystalplex

Customer profile

Ideal customer profiles1 record

Crystalplex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Crystalplex partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights3 records

Crystalplex competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: A dominant life-sciences tools and diagnostics incumbent that sells fluorescent reagents, particle-based assays, and imaging consumables, often competing with smaller nanoparticle specialists for the same biomedical research and pathology customers.
  • MilliporeSigma (Merck KGaA Life Science): Supplies an extensive catalog of fluorescent nanoparticles, dyes, and reagents for research and diagnostic workflows, representing a broad incumbent competitive reference point.
  • Luminex (DiaSorin): A molecular diagnostics and life-sciences research tools company whose bead-based and fluorescent assay platforms overlap with downstream uses of Crystalplex's fluorescent nanoparticle technology.

Direct peers

  • Cytodiagnostics: Develops and supplies gold and silver nanoparticles, including fluorescently labeled variants, to biomedical research, diagnostic, and life-sciences customers — closely aligned with Crystalplex's stated markets.
  • Ocean NanoTech: Specializes in fluorescent nanoparticles and quantum dots for biomedical research and diagnostic applications — the most direct functional overlap with Crystalplex's nanoparticle platform.
  • Nanocs: Manufactures functionalized and fluorescent nanoparticles, proteins, and bioconjugates sold into research and diagnostic applications, matching Crystalplex's product focus.
  • Bangs Laboratories: Supplies fluorescent and functionalized microparticles/nanoparticles for diagnostics, life-sciences research, and flow cytometry — directly comparable reagent offering.
  • Spherotech: Manufactures fluorescent and magnetic particles for diagnostic and research use, including flow cytometry applications, making it a directly comparable nanoparticle reagent vendor.

Emerging players

  • nanoComposix (Fortis Life Sciences): Designs and manufactures precisely engineered nanoparticles, including fluorescent versions, for diagnostics and life-sciences research customers.
  • CD Bioparticles: Offers a growing catalog of fluorescent and magnetic nanoparticles for diagnostics and drug delivery — an emerging participant in the same niche as Crystalplex.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights3 records

Customer concentration

Crystalplex social profiles

Digital presence

Crystalplex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Crystalplex leadership team

Management profile

Number of profiles

Profiles3 records

Crystalplex funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Crystalplex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crystalplex

What does Crystalplex do?

Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company develops and supplies nanomaterial-based reagents and tools that enable detection, labeling, and imaging applications for life-science researchers and clinical diagnostic developers. Its offerings center on proprietary fluorescent nanoparticle formulations tailored to research and diagnostic use cases.

When was Crystalplex founded?

Crystalplex was founded in 2004. It employs 1 to 10 people.

Where is Crystalplex based?

Crystalplex is headquartered in Pittsburgh, United States, in the North America region.

Who are Crystalplex's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, MilliporeSigma (Merck KGaA Life Science) and Luminex (DiaSorin). Direct peers are Cytodiagnostics, Ocean NanoTech, Nanocs, Bangs Laboratories and Spherotech. Emerging players are nanoComposix (Fortis Life Sciences) and CD Bioparticles.

Does Crystalplex have an API?

No public API is recorded for Crystalplex.

What industry is Crystalplex in?

Crystalplex's product category is Biomedical Research Reagents. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 541713 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals